Cooperative Agreement UE5FD008142
Award Date
9/30/23
Completion Date
9/30/27
Dollars Obligated
$4.3M
Funding Federal Agency
Center for Drug Evaluation and Research
Awarding Federal Agency
FDA Office of Acquisition and Grant Services
Federal Grant Program
93.103
Assistance Type
Cooperative Agreement
Place of Performance
Bethesda, MD 20814, USA
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $150,000 Cooperative Agreement under its CFDA 93.103 Food and Drug Administration Research program to the Pharmaceutical Inspection Co-Operation Scheme-Association De Droit Suisse in Switzerland. The award will support the implementation of Stage Two of the PIC/S Inspectorates' Academy (PIA), a web-based educational center aimed at harmonizing and standardizing Good Manufacturing Practice (GMP) training and qualification processes for...
The National Institute of General Medical Sciences (NIGMS) awarded Purdue University a $268,725 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to support the Purdue Drug Discovery Training Program (PDD-TP). The objective of the PDD-TP is to provide predoctoral students with cross-disciplinary training at the chemical-biology interface as it pertains to modern drug discovery. The 5-year program will train 3 new students annually, exposing them to a...
This Cooperative Agreement award of $298,422 from the Food and Drug Administration (FDA) under the FDA Research program (CFDA 93.103) will support the development of a semi-automated sequential surveillance system using tree-based scan statistics to monitor the safety and effectiveness of generic drug-device combinations compared to branded products. The research aims to rigorously describe patient utilization patterns, evaluate comparative safety and effectiveness outcomes, and systematically...
This $1.5 million cooperative agreement from the Department of Health and Human Services' Food and Drug Administration (FDA) Research program (CFDA 93.103) supports the development and validation of a best practices framework for physiologically-based pharmacokinetic (PBPK) analysis to support model-informed biowaivers of fed bioequivalence studies for Biopharmaceutics Classification System Class II drugs. The University of Florida is the primary awardee. Under the award, the University of...
The National Institute of General Medical Sciences (NIGMS) awarded a $314,363 Project Grant under CFDA 93.859 (Biomedical Research and Research Training) to Delineate Inc., a for-profit, woman-owned small business located in Medford, MA. The grant, which runs from April 1, 2025 to March 31, 2026, aims to develop an innovative platform that uses large language models (LLMs) to accelerate the building and repurposing of quantitative systems pharmacology (QSP) models from scientific literature. The...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $419,615 to support a 2-year postdoctoral training program in clinical pharmacology at Thomas Jefferson University and Children's Hospital of Philadelphia. The program aims to train the next generation of drug development scientists to advance innovation in therapeutics across pediatric,...
This $28,000,000 Cooperative Agreement awarded by the U.S. Food and Drug Administration (FDA) under the CFDA 93.103 Food and Drug Administration Research program aims to expand state, local, tribal, and territorial (SLTT) conformance with the Voluntary National Retail Food Regulatory Program Standards. The National Environmental Health Association (NEHA), the primary awardee, will work with the FDA and project partners to: 1) develop and improve a grant management system to administer...
The National Institute of General Medical Sciences (NIGMS) awarded a $358,862 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to GMJ Technologies, Inc., a minority-owned small business, to develop a microfluidic SDS depletion electrophoresis (SDE) interface. This interface will enable direct coupling of capillary electrophoresis with sodium dodecyl sulfate (CE-SDS) to mass spectrometry for improved characterization and quality control of monoclonal...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $100,005.00 to Emory University to develop and pilot the "Enhancing Access for Successful Evaluation (EASE) Learning Experience." The EASE Learning Experience aims to build evaluation capacity for biomedical research training programs by: 1) ensuring administrators and investigators acquire knowledge of effective...
This $300,000 Cooperative Agreement awarded by the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA) under the FDA Research program (CFDA 93.103) aims to develop physiologically based pharmacokinetic (PBPK) model-based mechanistic in vitro-in vivo correlations (IVIVC) for long-acting injectable (LAI) suspensions. The primary objectives are to: 1) Investigate the relationships between the physicochemical properties of Depo-Provera 150 formulations and...